Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms

Journal of Clinical Microbiology

Volumn 48, Issue 3, 2010, Pages 889-893

  Novak Weekley, Susan M ^a   Marlowe, Elizabeth M ^a   Miller, John M ^a   Cumpio, Joven ^a   Nomura, Jim H ^b   Vance, Paula H ^c   Weissfeld, Alice ^c  

^a SCPMG Regional Reference Laboratories   (United States)

^b KAISER PERMANENTE   (United States)

^c Microbiology Specialists Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; GLUTAMATE DEHYDROGENASE;

ALGORITHM; ARTICLE; CLINICAL LABORATORY; CLOSTRIDIUM DIFFICILE; ENZYME ASSAY; ENZYME IMMUNOASSAY; FECES ANALYSIS; HUMAN; INTERMETHOD COMPARISON; NONHUMAN; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TOXIN ANALYSIS;

ALGORITHMS; ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; BACTERIOLOGICAL TECHNIQUES; CELL CULTURE TECHNIQUES; CERCOPITHECUS AETHIOPS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; ENTEROTOXINS; FECES; GLUTAMATE DEHYDROGENASE; HUMANS; IMMUNOENZYME TECHNIQUES; NEUTRALIZATION TESTS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; VERO CELLS;

CLOSTRIDIUM DIFFICILE; NUCLEOPOLYHEDROVIRUS;

EID: 77749340505     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01801-09     Document Type: Article

References (34)

1. Akerlund, T., I. Persson, M. Unemo, T. Noren, B. Svenungsson, M. Wullt, and L. G. Burman. 2008. Increased sporulation rate of epidemic Clostridium difficile type 027/NAP1. J. Clin. Microbiol. 46:1530-1533.
2. Alcalá, L., L. Sanchez-Cambronero, M. P. Catalan, M. Sanchez-Somolinos, M. T. Pelaez, M. Marin, and E. Bouza. 2008. Comparison of three commercial methods for rapid detection of Clostridium difficile toxins A and B from fecal specimens. J. Clin. Microbiol. 46:3833-3835.
3. Alonso, R., C. Muñoz, S. Gros, D. García de Viedma, T. Peláez, and E. Bouza. 1999. Rapid detection of toxigenic Clostridium difficile from stool samples by a nested PCR of toxin B gene. J. Hosp. Infect. 41:145-149.
4. Arzese, A., G. Trani, L. Riul, and G. A. Botta. 1995. Rapid polymerase chain reaction method for specific detection of toxigenic Clostridium difficile. Eur. J. Clin. Microbiol. Infect. Dis. 14:716-719.
5. Bacci, S., G. St-Martin, B. Olesen, B. Bruun, K. E. Olsen, E. M. Nielsen, and K. Molbak. 2009. Outbreak of Clostridium difficile 027 in North Zealand, Denmark, 2008-2009. Euro Surveill. 14:19183.
6. Barbut, F., M. Braun, B. Burghoffer, V. Lalande, and C. Eckert. 2009. Rapid detection of toxigenic strains of Clostridium difficile in diarrheal stools by real-time PCR. J. Clin. Microbiol. 47:1276-1277.
7. Bartlett, J. G. 2006. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann. Intern. Med. 145:758-764.
8. Bartlett, J. G., and T. M. Perl. 2005. The new Clostridium difficile - what does it mean? N. Engl. J. Med. 353:2503-2505.
9. Brazier, J. S., B. Patel, and A. Pearson. 2007. Distribution of Clostridium difficile PCR ribotype 027 in British hospitals. Euro Surveill. 12:E070426.
10. Cardona, D. M., and K. H. Rand. 2008. Evaluation of repeat Clostridium difficile enzyme immunoassay testing. J. Clin. Microbiol. 46:3686-3689.
11. Coignard, B., F. Barbut, K. Blanckaert, J. M. Thiolet, I. Poujol, A. Carbonne, J. C. Petit, and J. C. Desenclos. 2006. Emergence of Clostridium difficile toxinotype III, PCR-ribotype 027-associated disease, France, 2006. Euro Surveill. 11:E060914.
12. Eastwood, K., P. Else, A. Charlett, and M. Wilcox. 2009. Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J. Clin. Microbiol. 47:3211-3217.
13. Gerding, D. N., C. A. Muto, and R. C. Owens, Jr. 2008. Measures to control and prevent Clostridium difficile infection. Clin. Infect. Dis. 46(Suppl. 1):S43-S49.
14. Gilligan, P. H. 2008. Is a two-step glutamate dehydrogenase antigen-cytotoxicity neutralization assay algorithm superior to the premier toxin A and B enzyme immunoassay for laboratory detection of Clostridium difficile? J. Clin. Microbiol. 46:1523-1525.
15. Gluck, L., J. Wehrlin, P. D. Stamper, W. Babiker, R. Alcabasa, D. Aird, I. Ikpeama, and K. C. Carroll. 2009. Comparison of the Prodesse ProGastro Cd real-time PCR to a commercial cytotoxin assay, abstr. S87. Poster Abstr. 25th Clin. Virol. Symp. Ann. Meet. Pan Am. Soc. Clin. Virol.
16. Johnson, S., M. H. Samore, K. A. Farrow, G. E. Killgore, F. C. Tenover, D. Lyras, J. I. Rood, P. DeGirolami, A. L. Baltch, M. E. Rafferty, S. M. Pear, and D. N. Gerding. 1999. Epidemics of diarrhea caused by a clindamycinresistant strain of Clostridium difficile in four hospitals. N. Engl. J. Med. 341:1645-1651.
17. Loo, V. G., L. Poirier, M. A. Miller, M. Oughton, M. D. Libman, S. Michaud, A. M. Bourgault, T. Nguyen, C. Frenette, M. Kelly, A. Vibien, P. Brassard, S. Fenn, K. Dewar, T. J. Hudson, R. Horn, P. Rene, Y. Monczak, and A. Dascal. 2005. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med. 353:2442-2449.
18. McFarland, L. V. 2009. Renewed interest in a difficult disease: Clostridium difficile infections - epidemiology and current treatment strategies. Curr. Opin. Gastroenterol. 25:24-35.
19. Monaghan, T., T. Boswell, and Y. R. Mahida. 2008. Recent advances in Clostridium difficile-associated disease. Gut 57:850-860.
20. Murabata, M., H. Kato, H. Yano, M. Ogura, J. Shibayama, Y. Wakimoto, Y. Arakawa, and M. Mizokami. 2008. Intestinal colonization and nosocomial spread of Clostridium difficile in pediatric cancer patients under long-term hospitalization. Kansenshogaku Zasshi 82:419-426.
21. Muto, C. A., M. K. Blank, J. W. Marsh, E. N. Vergis, M. M. O'Leary, K. A. Shutt, A. W. Pasculle, M. Pokrywka, J. G. Garcia, K. Posey, T. L. Roberts, B. A. Potoski, G. E. Blank, R. L. Simmons, P. Veldkamp, L. H. Harrison, and D. L. Paterson. 2007. Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach. Clin. Infect. Dis. 45:1266-1273.
22. Novak-Weekley, S. M., and M. H. Hollingsworth. 2008. Comparison of the premier toxin A and B assay and the TOX A/B II assay for diagnosis of Clostridium difficile infection. Clin. Vaccine Immunol. 15:575-578.
23. Peterson, L. R., R. U. Manson, S. M. Paule, D. M. Hacek, A. Robicsek, R. B. Thomson, Jr., and K. L. Kaul. 2007. Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin. Infect. Dis. 45:1152-1160.
24. Peterson, L. R., M. M. Olson, C. J. Shanholtzer, and D. N. Gerding. 1988. Results of a prospective, 18-month clinical evaluation of culture, cytotoxin testing, and culturette brand (CDT) latex testing in the diagnosis of Clostridium difficile-associated diarrhea. Diagn. Microbiol. Infect. Dis. 10:85-91.
25. Peterson, L. R., and A. Robicsek. 2009. Does my patient have Clostridium difficile infection? Ann. Intern. Med. 151:176-179.
26. Reller, M. E., C. A. Lema, T. M. Perl, M. Cai, T. L. Ross, K. A. Speck, and K. C. Carroll. 2007. Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. J. Clin. Microbiol. 45:3601-3605.
27. Shin, B. M., S. J. Yoo, and H. J. Oh. 2009. Comparison of two enzyme immunoassays for detection of Clostridium difficile toxin A and toxin B. Korean J. Lab. Med. 29:122-126. (In Korean.)
28. Sloan, L. M., B. J. Duresko, D. R. Gustafson, and J. E. Rosenblatt. 2008. Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection. J. Clin. Microbiol. 46:1996-2001.
29. Snell, H., M. Ramos, S. Longo, M. John, and Z. Hussain. 2004. Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the. C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea. J. Clin. Microbiol. 42:4863-4865.
30. Stamper, P. D., R. Alcabasa, D. Aird, W. Babiker, J. Wehrlin, I. Ikpeama, and K. C. Carroll. 2009. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J. Clin. Microbiol. 47:373-378.
31. Ticehurst, J. R., D. Z. Aird, L. M. Dam, A. P. Borek, J. T. Hargrove, and K. C. Carroll. 2006. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J. Clin. Microbiol. 44:1145-1149.
32. Warny, M., J. Pepin, A. Fang, G. Killgore, A. Thompson, J. Brazier, E. Frost, and L. C. McDonald. 2005. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366:1079-1084.
33. Yoo, S. J., J. O. Kang, H. J. Oh, and B. M. Shin. 2006. Comparison of two enzyme immunoassays for Clostridium difficile toxin A. Korean J. Lab. Med. 26:408-411. (In Korean.)
34. Zheng, L., S. F. Keller, D. M. Lyerly, R. J. Carman, C. W. Genheimer, C. A. Gleaves, S. J. Kohlhepp, S. Young, S. Perez, and K. Ye. 2004. Multicenter evaluation of a new screening test that detects Clostridium difficile in fecal specimens. J. Clin. Microbiol. 42:3837-3840.